新的生物标志物和治疗在三阴性乳腺癌的进展
Brahim El Hejjioui1,2, Salma Lamrabet1, Sarah Amrani Joutei3
1Biomedical and Translational Research Laboratory, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez 30050, Morocco.
Diagnostics (Basel, Switzerland)
|June 10, 2023
概括
三阴性乳腺癌 (TNBC) 是一种侵袭性乳腺癌亚型. 这篇评论详细介绍了TNBC分子亚型,生物标志物,奥米克方法以及新兴的新辅助疗法,如免疫疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种异质的亚型,预后不佳,侵袭性高,转移潜力强.
- 由于TNBC缺乏雌激素受体,孕激素受体和HER2放大的表达,使治疗策略复杂化.
研究的目的:
- 审查TNBC的分子亚型和病理方面.
- 要突出关键的生物标记特征,包括扩散,迁移,血管生成,亡,DNA损伤反应,免疫检查点和表观遗传修饰的调节者.
- 讨论omics方法和TNBC最新的新辅助治疗方法.
主要方法:
- 文献综述侧重于TNBC的分子和病理特征.
- 分析生物标志物概况,包括细胞增殖,迁移,血管新生,细胞亡,DNA损伤反应,免疫检查点和表观遗传修饰.
- 探索奥米克技术 (基因组学,表观遗传学,转录组学) 和当前的新辅助疗法.
主要成果:
- TNBC表现出多样化的分子亚型和关键生物标志物配置文件.
- 奥米克斯方法提供了对TNBC特异性突变,表观遗传改变和基因表达模式的洞察.
- 免疫疗法和新型向药物代表了TNBC新辅助治疗策略的有希望的进展.
结论:
- 了解TNBC异质性和生物标志物对于开发有效疗法至关重要.
- 奥米克技术对于解开TNBC复杂性和识别治疗点至关重要.
- 新辅助治疗的进步,特别是免疫疗法,为改善TNBC患者的治疗结果提供了新的希望.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...